Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. - Wikidata - wikimedia - TriplyDB

Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.

Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.

http://www.wikidata.org/entity/Q34728024

about

Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Analgesic Activities.Risk factors and biomarkers of age-related macular degeneration.Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration.Tear film proteome in age-related macular degeneration.

P2860

Q28551885-24EB25DC-3FA7-49F7-98A7-9EAA6F2F42EF Q33611455-4F0917C7-9DE1-4498-BE02-CC14407C404B Q38709294-F76E769E-8825-4A41-921B-E9E0DB28895B Q38828895-A105932C-BF1C-40E2-A372-2D6B09E714DE Q39110045-3C01886B-8461-4C58-AB68-86F3A14E03F4 Q42328244-DEED5EA4-D84D-448D-A411-3184A330656D Q54980186-92079662-8FC9-40F0-B0F1-64D52F754FDA

P2860

Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.

http://www.wikidata.org/entity/Q34728024

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prevalence of anti-retinal aut ...... -related macular degeneration.

@ast

Prevalence of anti-retinal aut ...... -related macular degeneration.

@en

Prevalence of anti-retinal aut ...... -related macular degeneration.

@nl

type

label

Prevalence of anti-retinal aut ...... -related macular degeneration.

@ast

Prevalence of anti-retinal aut ...... -related macular degeneration.

@en

Prevalence of anti-retinal aut ...... -related macular degeneration.

@nl

prefLabel

Prevalence of anti-retinal aut ...... -related macular degeneration.

@ast

Prevalence of anti-retinal aut ...... -related macular degeneration.

@en

Prevalence of anti-retinal aut ...... -related macular degeneration.

@nl

P1433

Q34728024-155210A6-0845-40FB-A6CB-70AF24368D46

P1476

Q34728024-9B498D69-F8B4-436E-B7F4-21DCDF55CE49

P2093

Q34728024-A4D5CE54-29FD-419B-828D-742CC0B91F54

Q34728024-A9FD4D78-BD88-46F8-943B-9F335C7DB149

Q34728024-C72AC332-BEC0-4C10-B454-C0BA93289F90

P2860

Q34728024-01EAB0B8-ECF1-4B2B-9F07-F3139027B0A5

Q34728024-0796CA96-8334-4B75-847E-5A37D588EBFC

Q34728024-0F53BDF4-6345-4ABD-9F1B-40940703D674

Q34728024-11C27868-C656-4936-BC47-08F7FB4166DB

Q34728024-182420B6-A557-42A1-B7E5-0D50B34D41F7

Q34728024-23C3903B-41DE-44B0-AA60-9E09C5CC5CA9

Q34728024-2B5DEE17-0456-46C8-A4A9-BB7483C5E55E

Q34728024-2E0D22E2-3384-40D9-BE95-D02E9A789748

Q34728024-328132DB-9DED-4B4D-A3AB-0C628A541038

Q34728024-3F5D48FE-2BFB-41AA-874B-D10341A99993

P2888

Q34728024-C97E0918-28F7-45A0-9665-496CFAF942EA

P304

Q34728024-5223F2A1-74A8-4E25-83BB-2A4862AEA81E

P31

Q34728024-9430581B-7EBF-459A-9C73-4225F0C80F8C

P356

Q34728024-ACE324DF-3DCA-4D09-9403-D9D8155AF54E

P478

Q34728024-E6758622-2C25-4C5D-80F6-2ED6FEF36085

P50

Q34728024-F5507038-F4E3-4DA7-B437-40D8AACC343A

P577

Q34728024-244BC237-90D7-4988-9230-C59F2D5BB966

P5875

Q34728024-BAFE518F-F6DC-4516-8A89-6E1CC102D8C4

P6179

Q34728024-41D94509-AB6E-474F-930E-3669A62A60E6

P698

Q34728024-4ED74CB7-ADB5-4C28-9873-DF70CE154ECB

P921

Q34728024-265C4DF9-0612-4E9B-A755-BC5FF5AA2ACB

P932

Q34728024-220762E6-4192-4862-AF94-C82CFD7BDBAA

P356

1471-2415-14-154

P1433

BMC Ophthalmology

P1476

Prevalence of anti-retinal aut ...... -related macular degeneration.

@en

P2093

Frederick L Ferris

http://www.w3.org/2001/XMLSchema#string

Grazyna Adamus

http://www.w3.org/2001/XMLSchema#string

Michael L Klein

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

A look at autoimmunity and inflammation in the eye

Complement in age-related macular degeneration: a focus on function

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration

Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy

CEP biomarkers as potential tools for monitoring therapeutics

Risk factors for age-related macular degeneration.

Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.

Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.

Immunological and aetiological aspects of macular degeneration.

P2888

1471-2415-14-154

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2415-14-154

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269413556

http://www.w3.org/2001/XMLSchema#string

P6179

1029587292

http://www.w3.org/2001/XMLSchema#string

P698

25488058

http://www.w3.org/2001/XMLSchema#string

P921

P932

4269864

http://www.w3.org/2001/XMLSchema#string